Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingmin Chen

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Pain|May 26, 2026
Distribution of divalent small interfering RNA into neurons of sensory ganglia produces selective, durable knockdown of Nav1.7 and strong analgesiaCorrie L Gallant-Behm, Justin N Siemian, David Tran, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Cancer Letters|July 16, 2021
New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []Min Wang, Ding Ding, Tingting Qin, et al.
Epilepsia|January 28, 2025
Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNABenjamin J Andreone, Jennifer Lin, Jenna Tocci, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 27, 2021
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumorsHebin Wang, Ding Ding, Tingting Qin, et al.
The New England Journal of Medicine|August 30, 2013
Safety and efficacy of RNAi therapy for transthyretin amyloidosisTeresa Coelho, David Adams, Ana Silva, et al.
Nature Biotechnology|January 19, 2010
Rational design of cationic lipids for siRNA deliverySean C Semple, Akin Akinc, Jianxin Chen, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Pain|May 26, 2026
Distribution of divalent small interfering RNA into neurons of sensory ganglia produces selective, durable knockdown of Nav1.7 and strong analgesiaCorrie L Gallant-Behm, Justin N Siemian, David Tran, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 2, 2016
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosisJames S Butler, Amy Chan, Susete Costelha, et al.
Cancer Letters|July 16, 2021
New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []Min Wang, Ding Ding, Tingting Qin, et al.
Epilepsia|January 28, 2025
Durable suppression of seizures in a preclinical model of KCNT1 genetic epilepsy with divalent small interfering RNABenjamin J Andreone, Jennifer Lin, Jenna Tocci, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 27, 2021
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumorsHebin Wang, Ding Ding, Tingting Qin, et al.
The New England Journal of Medicine|August 30, 2013
Safety and efficacy of RNAi therapy for transthyretin amyloidosisTeresa Coelho, David Adams, Ana Silva, et al.
Nature Biotechnology|January 19, 2010
Rational design of cationic lipids for siRNA deliverySean C Semple, Akin Akinc, Jianxin Chen, et al.
Pageof 11